Buscar
Mostrando ítems 61-70 de 10347
Chorismate synthase: An attractive target for drug development against orphan diseases
(2007-03-01)
The increase in incidence of infectious diseases worldwide, particularly in developing countries, is worrying. Each year, 14 million people are killed by infectious diseases, mainly HIV/AIDS, respiratory infections, malaria ...
Kinetic parameters for thermal decomposition of supramolecular polymers derived from diclofenac-meglumine supramolecular adducts
(2013-01-25)
Meglumine is an aminocarbohydrate able to form supramolecular adducts with organic acids. The recognition is based on hydrogen bonds and the structures resulting from the complexation have high solubility in water. This ...
Kinetic parameters for thermal decomposition of supramolecular polymers derived from diclofenac-meglumine supramolecular adducts
(2013-01-25)
Meglumine is an aminocarbohydrate able to form supramolecular adducts with organic acids. The recognition is based on hydrogen bonds and the structures resulting from the complexation have high solubility in water. This ...
Amphetamine derivatives as monoamine oxidase inhibitors
(Frontiers Media S.A., 2020)
Antifungal toxicity of linear geranylphenol. Influence of oxigenate substituents
(Elsevier Ltd, 2017)
Validation of microbiological assay for determination of cefuroxime in injectable preparations
(2012-08-22)
The validation of a microbiological assay, applying agar diffusion method for determination of the active of cefuroxime in power for injection, is described. Using a strain of Micrococcus luteus ATCC 9341 as the test ...
Validation of microbiological assay for determination of cefuroxime in injectable preparations
(2012-08-22)
The validation of a microbiological assay, applying agar diffusion method for determination of the active of cefuroxime in power for injection, is described. Using a strain of Micrococcus luteus ATCC 9341 as the test ...
Drug leads for interactive protein targets with unknown structure
(Elsevier, 2016-04)
The disruption of protein?protein interfaces (PPIs) remains a challenge in drug discovery. The problem becomes daunting when the structure of the target protein is unknown and is even further complicated when the interface ...